The life sciences sector in the United Kingdom is encountering significant challenges as new reforms regarding the National Health Service (NHS) drug evaluation process come into effect. Johan Kahlstrom, the
The life sciences sector in the United Kingdom is encountering significant challenges as new reforms regarding the National Health Service (NHS) drug evaluation process come into effect. Johan Kahlstrom, the






